These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17585859)

  • 21. Familial trends of inheritance in gastro esophageal reflux disease, Barrett's esophagus and Barrett's adenocarcinoma: 20 families.
    Sappati Biyyani RS; Chessler L; McCain E; Nelson K; Fahmy N; King J
    Dis Esophagus; 2007; 20(1):53-7. PubMed ID: 17227311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Barrett's esophagus with high-grade dysplasia.
    McAllaster JD; Buckles D; Al-Kasspooles M
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Columnar lined (Barrett's) esophagus: future perspectives.
    Bani-Hani KE; Bani-Hani BK
    J Gastroenterol Hepatol; 2008 Feb; 23(2):178-91. PubMed ID: 17854426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of obesity in Barrett's esophagus and cancer.
    Murray L; Romero Y
    Surg Oncol Clin N Am; 2009 Jul; 18(3):439-52. PubMed ID: 19500735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinoma.
    MacDonald K; Porter GA; Guernsey DL; Zhao R; Casson AG
    Cancer Epidemiol; 2009 Jul; 33(1):37-40. PubMed ID: 19679045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.
    Levine DM; Ek WE; Zhang R; Liu X; Onstad L; Sather C; Lao-Sirieix P; Gammon MD; Corley DA; Shaheen NJ; Bird NC; Hardie LJ; Murray LJ; Reid BJ; Chow WH; Risch HA; Nyrén O; Ye W; Liu G; Romero Y; Bernstein L; Wu AH; Casson AG; Chanock SJ; Harrington P; Caldas I; Debiram-Beecham I; Caldas C; Hayward NK; Pharoah PD; Fitzgerald RC; Macgregor S; Whiteman DC; Vaughan TL
    Nat Genet; 2013 Dec; 45(12):1487-93. PubMed ID: 24121790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 in esophageal adenocarcinoma: a critical reassessment of mutation frequency and identification of 72Arg as the dominant allele.
    Chung SM; Kao J; Hyjek E; Chen YT
    Int J Oncol; 2007 Dec; 31(6):1351-5. PubMed ID: 17982662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management strategies for Barrett's esophagus.
    Hillman L
    J Gastroenterol Hepatol; 2007 Jun; 22(6):771-2. PubMed ID: 17565627
    [No Abstract]   [Full Text] [Related]  

  • 29. Low incidence of adenocarcinoma and high-grade intraepithelial neoplasia in patients with Barrett's esophagus: a prospective cohort study.
    Martinek J; Benes M; Brandtl P; Hucl T; Vasicek M; Voska L; Lanska V; Nosek V; Spicak J
    Endoscopy; 2008 Sep; 40(9):711-6. PubMed ID: 18698534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Barrett's: do we still need goblet cells for diagnosis?
    Lenglinger J; Riegler M
    Am J Gastroenterol; 2009 Sep; 104(9):2355-6; author reply 2356-7. PubMed ID: 19727095
    [No Abstract]   [Full Text] [Related]  

  • 31. Risk factors for esophageal cancer development.
    Falk GW
    Surg Oncol Clin N Am; 2009 Jul; 18(3):469-85. PubMed ID: 19500737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in gene chip technique in Barrett's metaplasia and adenocarcinoma.
    Wang XW; Gao HJ; Fang DC
    J Dig Dis; 2008 May; 9(2):68-71. PubMed ID: 18419638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular markers and genetics in cancer development.
    Hormi-Carver K; Souza RF
    Surg Oncol Clin N Am; 2009 Jul; 18(3):453-67. PubMed ID: 19500736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barrett's Esophagus and esophageal adenocarcinoma.
    Bresalier RS
    Annu Rev Med; 2009; 60():221-31. PubMed ID: 18783330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving screening practices for Barrett's esophagus.
    Shaheen NJ; Palmer LB
    Surg Oncol Clin N Am; 2009 Jul; 18(3):423-37. PubMed ID: 19500734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular epidemiology of and genetic susceptibility to esophageal cancer.
    Bajpai M; Das KM; Lefferts J; Lisovsky M; Mashimo H; Phillips WA; Srivastava A; To H
    Ann N Y Acad Sci; 2014 Sep; 1325():40-8. PubMed ID: 25266013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A segregation analysis of Barrett's esophagus and associated adenocarcinomas.
    Sun X; Elston R; Barnholtz-Sloan J; Falk G; Grady WM; Kinnard M; Mittal SK; Willis JE; Markowitz S; Brock W; Chak A
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):666-74. PubMed ID: 20200424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gastroesophageal reflux disease and malignancy].
    Richert Z; Robaszkiewicz M
    Rev Prat; 2008 Sep; 58(13):1414-5, 1417, 1419-20. PubMed ID: 18924321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
    Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and recognition of early esophageal neoplasia.
    Herszényi L; Pregun I; Tulassay Z
    Dig Dis; 2009; 27(1):24-30. PubMed ID: 19439957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.